R-RAS2 overexpression in tumors of the human central nervous system

Molecular Cancer

Volumn 12, Issue 1, 2013, Pages

  Gutierrez Erlandsson, Sylvia ^a   Herrero Vidal, Pedro ^a   Fernandez Alfara, Marcos ^a   Hernandez Garcia, Susana ^a   Gonzalo Flores, Sandra ^a   Mudarra Rubio, Alberto ^a   Fresno, Manuel ^a   Cubelos, Beatriz ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

CNS tumors; R RAS2; RAS family proteins; TC21

Indexed keywords

MESSENGER RNA; R RAS2 PROTEIN; RAS PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; ASTROCYTOMA; BRAIN TISSUE; BRAIN TUMOR; CANCER GRADING; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; EPENDYMOMA; FEMALE; GENE OVEREXPRESSION; GLIOBLASTOMA; GLIOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; MENINGIOMA; MIDDLE AGED; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIOMA; PRECANCER; SCHOOL CHILD; TUMOR GROWTH; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; FEMALE; GENE EXPRESSION; GLIOMA; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MONOMERIC GTP-BINDING PROTEINS; RNA, MESSENGER; TISSUE ARRAY ANALYSIS; YOUNG ADULT;

EID: 84886006682     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-12-127     Document Type: Article

References (30)

1. Karnoub AE, Weinberg RA. Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 2008, 9:517-531. 10.1038/nrm2438, 18568040.
2. Ehrhardt A, Ehrhardt GR, Guo X, Schrader JW. Ras and relatives-job sharing and networking keep an old family together. Exp Hematol 2002, 30:1089-1106. 10.1016/S0301-472X(02)00904-9, 12384139.
3. Alarcon B, Martinez-Martin N. RRas2, RhoG and T-cell phagocytosis. Small 2011, 3:97-101. 110.4161/sgtp.19138.
4. Graham SM, Oldham SM, Martin CB, Drugan JK, Zohn IE, Campbell S, Der CJ. TC21 and Ras share indistinguishable transforming and differentiating activities. Oncogene 1999, 18:2107-2116. 10.1038/sj.onc.1202517, 10321735.
5. Cox AD, Brtva TR, Lowe DG, Der CJ. R-Ras induces malignant, but not morphologic, transformation of NIH3T3 cells. Oncogene 1994, 9:3281-3288.
6. Chan AM, Miki T, Meyers KA, Aaronson SA. A human oncogene of the RAS superfamily unmasked by expression cDNA cloning. Proc Natl Acad Sci U S A 1994, 91:7558-7562. 10.1073/pnas.91.16.7558, 44441, 8052619.
7. Huang Y, Saez R, Chao L, Santos E, Aaronson SA, Chan AM. A novel insertional mutation in the TC21 gene activates its transforming activity in a human leiomyosarcoma cell line. Oncogene 1995, 11:1255-1260.
8. Barker KT, Crompton MR. Ras-related TC21 is activated by mutation in a breast cancer cell line, but infrequently in breast carcinomas in vivo. Br J Cancer 1998, 78:296-300. 10.1038/bjc.1998.490, 2063018, 9703274.
9. Sharma R, Sud N, Chattopadhyay TK, Ralhan R. TC21/R-Ras2 upregulation in esophageal tumorigenesis: potential diagnostic implications. Oncol 2005, 69:10-18. Epub 2005 Jul 2028.
10. Clark GJ, Kinch MS, Gilmer TM, Burridge K, Der CJ. Overexpression of the Ras-related TC21/R-Ras2 protein may contribute to the development of human breast cancers. Oncogene 1996, 12:169-176.
11. Lee JH, Pyon JK, Lee SH, Lee YJ, Kang SG, Kim CH, Kim DW, Nam HS, Park YH, Jeong DJ, Cho MK. Greater expression of TC21/R-ras2 in highly aggressive malignant skin cancer. Int J Dermatol 2011, 50:956-960. 910.1111/j.1365-4632.2010.04846.x, 10.1111/j.1365-4632.2010.04846.x, 21781067.
12. Delgado P, Cubelos B, Calleja E, Martinez-Martin N, Cipres A, Merida I, Bellas C, Bustelo XR, Alarcon B. Essential function for the GTPase TC21 in homeostatic antigen receptor signaling. Nat Immunol 2009, 10:880-888. Epub 2009 Jun 2028, 10.1038/ni.1749, 19561613.
13. Larive RM, Abad A, Cardaba CM, Hernandez T, Canamero M, de Alava E, Santos E, Alarcon B, Bustelo XR. The Ras-like protein R-Ras2/TC21 is important for proper mammary gland development. Mol 2012, 23:2373-2387. Epub 2012 Apr 2325.
14. Rodriguez-Viciana P, Sabatier C, McCormick F. Signaling specificity by Ras family GTPases is determined by the full spectrum of effectors they regulate. Mol Cell Biol 2004, 24:4943-4954. 10.1128/MCB.24.11.4943-4954.2004, 416418, 15143186.
15. Rosario M, Paterson HF, Marshall CJ. Activation of the Ral and phosphatidylinositol 3′ kinase signaling pathways by the ras-related protein TC21. Mol Cell Biol 2001, 21:3750-3762. 10.1128/MCB.21.11.3750-3762.2001, 87018, 11340168.
16. Erdogan M, Pozzi A, Bhowmick N, Moses HL, Zent R. Signaling pathways regulating TC21-induced tumorigenesis. J Biol Chem 2007, 282:27713-27720. Epub 22007 Jul 27726, 10.1074/jbc.M703037200, 17656362.
17. Rong R, He Q, Liu Y, Sheikh MS, Huang Y. TC21 mediates transformation and cell survival via activation of phosphatidylinositol 3-kinase/Akt and NF-kappaB signaling pathway. Oncogene 2002, 21:1062-1070. 10.1038/sj.onc.1205154, 11850823.
18. Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Ilyasova D, Kruchko C, McCarthy BJ, Rajaraman P, Schwartzbaum JA, et al. Brain tumor epidemiology: consensus from the brain tumor epidemiology consortium. Cancer 2008, 113:1953-1968. 1910.1002/cncr.23741, 10.1002/cncr.23741, 2861559, 18798534.
19. Hu X, Pandolfi PP, Li Y, Koutcher JA, Rosenblum M, Holland EC. mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma. Neoplasia 2005, 7:356-368. 10.1593/neo.04595, 1501155, 15967113.
20. Guha A, Feldkamp MM, Lau N, Boss G, Pawson A. Proliferation of human malignant astrocytomas is dependent on Ras activation. Oncogene 1997, 15:2755-2765. 10.1038/sj.onc.1201455, 9419966.
21. Mawrin C, Sasse T, Kirches E, Kropf S, Schneider T, Grimm C, Pambor C, Vorwerk CK, Firsching R, Lendeckel U, Dietzmann K. Different activation of mitogen-activated protein kinase and Akt signaling is associated with aggressive phenotype of human meningiomas. Clin Cancer Res 2005, 11:4074-4082. 10.1158/1078-0432.CCR-04-2550, 15930342.
22. Knobbe CB, Reifenberger J, Reifenberger G. Mutation analysis of the Ras pathway genes NRAS, HRAS, KRAS and BRAF in glioblastomas. Acta Neuropathol 2004, 108:467-470. Epub 2004 Oct 2028, 10.1007/s00401-004-0929-9, 15517309.
23. Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012, 9:671-675. 10.1038/nmeth.2089, 22930834.
24. Murphy GA, Graham SM, Morita S, Reks SE, Rogers-Graham K, Vojtek A, Kelley GG, Der CJ. Involvement of phosphatidylinositol 3-kinase, but not RalGDS, in TC21/R-Ras2-mediated transformation. J Biol Chem 2002, 277:9966-9975. Epub 2002 Jan 9911, 10.1074/jbc.M109059200, 11788587.
25. Okkenhaug K, Bilancio A, Farjot G, Priddle H, Sancho S, Peskett E, Pearce W, Meek SE, Salpekar A, Waterfield MD, et al. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Sci 2002, 297:1031-1034. Epub 2002 Jul 1018.
26. Bonneau D, Longy M. Mutations of the human PTEN gene. Hum Mutat 2000, 16:109-122. 10.1002/1098-1004(200008)16:2<109::AID-HUMU3>3.0.CO;2-0, 10923032.
27. Karakas B, Bachman KE, Park BH. Mutation of the PIK3CA oncogene in human cancers. Br J Cancer 2006, 94:455-459. 10.1038/sj.bjc.6602970, 2361173, 16449998.
28. Cantley LC. The phosphoinositide 3-kinase pathway. Sci 2002, 296:1655-1657.
29. Bader AG, Kang S, Zhao L, Vogt PK. Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 2005, 5:921-929. 10.1038/nrc1753, 16341083.
30. Luo J, Sobkiw CL, Logsdon NM, Watt JM, Signoretti S, OConnell F, Shin E, Shim Y, Pao L, Neel BG, et al. Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN+/- mice by the p85 regulatory subunits of phosphoinositide 3-kinase. Proc Natl Acad Sci U S A 2005, 102:10238-10243. 10.1073/pnas.0504378102, 1174923, 16006513.